Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways
Viruses · 2025
DOI: 10.3390/v17050703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Armando S Flores-Torres und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA. Hauptthemen laut MEDLINE: Glycolysis, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIAID).
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract viral infection in infants and causes around 60,000 in-hospital deaths annually. Emerging evidence suggests that RSV induces metabolic changes in host cells to support viral replication, presenting a potential target for therapeutic intervention. To investigate RSV-driven metabolic changes in situ, we combined positron emission tomography (PET), live-cell bioenergetics, and metabolomic profiling in the upper and lower airways of children. PET imaging revealed persistent, hyper-glycolytic regions in the lungs of RSV-infected children. Bioenergetic analysis of freshly collected nasopharyngeal aspirates from infants showed live upper respiratory cells (URCs) infected with RSV in situ exhibited significantly higher levels of glycolysis, glycolytic capacity, glycolytic reserves, and mitochondrial respiration than uninfected controls. Metabolomic analysis of nasopharyngeal fluids from these patients revealed distinct metabolic signatures, including increased citrate and malate, and decreases in taurine. In vitro infection of pediatric nasopharynx tissue-derived multicellular epithelial cultures (TEpiCs) and bronchial epithelial cells further confirmed RSV-induced increases in glycolysis. Together, these findings demonstrate that RSV infection induces hypermetabolism in both upper and lower primary airways in situ, supporting the potential of host-targeted metabolic interventions as a therapeutic strategy—particularly in vulnerable populations such as infants for whom vaccines are not currently available.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA.
- Department of Biological Sciences, Louisiana State University, Pennington Biomedical Research Center, Baton Rouge, LA 70803, USA.
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
ORCID-Profile: Armando S Flores-Torres, Stephania A Cormier
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (NIAID)
- Le Bonheur Children’s Hospital and the Children’s Foundation Research Institute
Zitieren
APA
Flores-Torres, A. S., Rezinciuc, S., Bezavada, L., Shulkin, B. L., Cormier, S. A., & Smallwood, H. S. (2025). Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways. Viruses. https://doi.org/10.3390/v17050703
Vancouver
Flores-Torres AS, Rezinciuc S, Bezavada L, Shulkin BL, Cormier SA, Smallwood HS. Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways. Viruses. 2025. doi:10.3390/v17050703
BibTeX
@article{FloresTorres2025,
author = {Flores-Torres, Armando S and Rezinciuc, Svetlana and Bezavada, Lavanya and Shulkin, Barry L and Cormier, Stephania A and Smallwood, Heather S},
title = {Respiratory Syncytial Virus Elicits Glycolytic Metabolism in Pediatric Upper and Lower Airways},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050703}
}
EUVIMED